These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 23485556

  • 1. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
    Ueda T, Honda M, Horimoto K, Aburatani S, Saito S, Yamashita T, Sakai Y, Nakamura M, Takatori H, Sunagozaka H, Kaneko S.
    Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
    [Abstract] [Full Text] [Related]

  • 2. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
    Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S.
    Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
    [Abstract] [Full Text] [Related]

  • 3. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC, Lee YS, Lin SE, Wu HY, Chen TC, Lee WC, Chen MF, Tsai CN.
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [Abstract] [Full Text] [Related]

  • 4. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS, Su ZR, Lee YP, Liu IT, Yen CJ.
    World J Gastroenterol; 2016 Jun 14; 22(22):5183-92. PubMed ID: 27298561
    [Abstract] [Full Text] [Related]

  • 5. Wnt-1 protein as a prognostic biomarker for hepatitis B-related and hepatitis C-related hepatocellular carcinoma after surgery.
    Lee HH, Uen YH, Tian YF, Sun CS, Sheu MJ, Kuo HT, Koay LB, Lin CY, Tzeng CC, Cheng CJ, Tang LY, Tsai SL, Wang AH.
    Cancer Epidemiol Biomarkers Prev; 2009 May 14; 18(5):1562-9. PubMed ID: 19423534
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
    Cheng AS, Chan HL, To KF, Leung WK, Chan KK, Liew CT, Sung JJ.
    Int J Oncol; 2004 Apr 14; 24(4):853-60. PubMed ID: 15010822
    [Abstract] [Full Text] [Related]

  • 7. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y, Honma K, Takemasa I, Nakamori S, Kita-Matsuo H, Motoori M, Nagano H, Dono K, Ochiya T, Monden M, Kato K.
    Int J Oncol; 2006 Feb 14; 28(2):383-91. PubMed ID: 16391793
    [Abstract] [Full Text] [Related]

  • 8. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.
    J Viral Hepat; 2005 Nov 14; 12(6):635-41. PubMed ID: 16255765
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
    Okamoto Y, Shinjo K, Shimizu Y, Sano T, Yamao K, Gao W, Fujii M, Osada H, Sekido Y, Murakami S, Tanaka Y, Joh T, Sato S, Takahashi S, Wakita T, Zhu J, Issa JP, Kondo Y.
    Gastroenterology; 2014 Feb 14; 146(2):562-72. PubMed ID: 24184133
    [Abstract] [Full Text] [Related]

  • 10. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 14; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 11. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku A, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y.
    Cancer Res; 2002 Jul 15; 62(14):3939-44. PubMed ID: 12124323
    [Abstract] [Full Text] [Related]

  • 12. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.
    Ann Surg Oncol; 2006 Jul 15; 13(7):947-54. PubMed ID: 16788756
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma.
    Lin KJ, Lin TM, Wang CH, Liu HC, Lin YL, Eng HL.
    Hum Pathol; 2013 Apr 15; 44(4):534-41. PubMed ID: 23069256
    [Abstract] [Full Text] [Related]

  • 14. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
    Lee SY, Song KH, Koo I, Lee KH, Suh KS, Kim BY.
    Genomics; 2012 Jun 15; 99(6):347-54. PubMed ID: 22564472
    [Abstract] [Full Text] [Related]

  • 15. Differential expression profiles of sense and antisense transcripts between HCV-associated hepatocellular carcinoma and corresponding non-cancerous liver tissue.
    Nagai K, Kohno K, Chiba M, Pak S, Murata S, Fukunaga K, Kobayashi A, Yasue H, Ohkohchi N.
    Int J Oncol; 2012 Jun 15; 40(6):1813-20. PubMed ID: 22366890
    [Abstract] [Full Text] [Related]

  • 16. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM.
    Genomics; 2013 Aug 15; 102(2):74-83. PubMed ID: 23583669
    [Abstract] [Full Text] [Related]

  • 17. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H, Wink J, Alers JC, de Man RA, IJzermans JN, Zondervan PE.
    Acta Histochem; 2003 Aug 15; 105(1):29-41. PubMed ID: 12666986
    [Abstract] [Full Text] [Related]

  • 18. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY, Kim JM, Oh JH, Jeon YJ, Lee DS, Kim JH, Choi JY, Ahn BM, Kim S, Yoo HS, Kim YS, Kim NS.
    Int J Oncol; 2006 Aug 15; 29(2):315-27. PubMed ID: 16820872
    [Abstract] [Full Text] [Related]

  • 19. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
    Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.
    J Pathol; 2000 Oct 15; 192(2):207-15. PubMed ID: 11004697
    [Abstract] [Full Text] [Related]

  • 20. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI, Kim JM, Jung GO, Chun JM, Choi GS, Park JB, Kwon CH, Kim SJ, Jo JW.
    Korean J Hepatol; 2008 Jun 15; 14(2):185-96. PubMed ID: 18617766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.